CMR — Center for Molecular Research
Samarium-153
Art. N°
Hover to zoom · click to enlarge
Radionuclides
Used in oncology for sustained reduction of pain intensity caused by metastatic bone lesions, and for rheumatic patients with pronounced pain syndrome. 153Sm is also highly effective in the diagnosis and treatment of prostate and breast cancer.
- Grade
- Non-carrier added radionuclide; GMP product; tested for sterility and bacterial endotoxins
- Half-life
- 1.93 days
- Appearance
- Transparent, clear colorless solution
- Concentration
- 15.0-25.0 mg/ml
- Radiochemical purity
- >= 95%
- Radionuclide impurities
- <= 3x10^-3%
- Sodium chloride content
- 4.0-6.0 mg/ml
